BioGaia's board of directors has decided to appoint Axel Sjöblad as the new Managing Director of BioGaia AB. Peter Rothschild has been appointed as Group President. It is with satisfaction that BioGaia announced this change, which will enable the company to increase its focus on sales and marketing while at the same time realizing the major development potential that the board sees for the group.

Axel Sjöblad, who is currently Managing Director of Getinge Sverige AB and VP North and Central Europe and was previously Regional VP Northern European Markets at Gambro Lundia AB, will assume duties as Managing Director of the company by March 1, 2016 at the latest. In the capacity of Group President, Peter Rothschild will retain overall responsibility for the BioGaia Group's research and development activities and will serve as working Chairman of the group companies TwoPac (BioGaia's production company), IBT (BioGaia's venture to develop a drug for premature newborns), and CapAble (BioGaia's venture in innovative delivery systems). He will also support the development of BioGaia Japan.

Furthermore, Peter Rothschild will continue as Chairman of Metabogen.